YOU MATTER.
Upcoming Events
Kidney Cancer Association 2018 Patient Meeting
September 22 - September 23Seventeenth International Kidney Cancer Symposium
November 2 - November 3Charlotte Kidney Cancer Support Group – Holiday Luncheon
November 26 @ 1:00 pm - 3:30 pm
Publications
0
%
5-Year Survival Rate Percentage increase from 2007 through 2013
0
Estimated new cases in the US, this year
0
Estimated Deaths in the US, this year
0
People are living with kidney and renal pelvis cancer, according to NCI SEER data from 2014
Evaluate your treatment options and make decisions
From the Pressroom
Videos: 2017 Kidney Cancer Association Patient & Survivor Conference
Videos from KCA patient and survivor conference that held in North Carolina on December 9th, 2017 is now available online.
FDA Grants Breakthrough Designation for Avelumab in Combination with INLYTA in Advanced Renal Cell Carcinoma
A combination approach with an immunotherapy, whose activity may complement existing agents such as INLYTA, has the potential to improve outcomes for patients with advanced renal cancer…
FDA Approves Adjuvant Sunitinib for High-Risk RCC
The FDA has approved sunitinib (Sutent) for use as an adjuvant therapy in patients with renal cell carcinoma (RCC) who have received nephrectomy and are high risk for recurrence.
YOU MATTER.
WE CARE.
YOU ARE NOT ALONE.
19 hours ago
The latest Cancer News Daily! https://t.co/1GaxNKLlQt Thanks to @4GatoNegro4 @pasahely3 @bcnow_scotland #cancer #health
The latest Cancer News Daily! https://t.co/1GaxNKLlQt Thanks to @4GatoNegro4 @pasahely3 @bcnow_scotland #cancer #health
The latest Cancer News Daily! https://t.co/1GaxNKLlQt Thanks to @4GatoNegro4 @pasahely3 @bcnow_scotland #cancer #health
— Kidney Cancer (@KidneyCancer) May 23, 2018
1 day ago
The latest Cancer News Daily! https://t.co/9sIY3oWcNV Thanks to @Throb14711 @KhalidAwan7940 @sloane_menkes #cancer #job
The latest Cancer News Daily! https://t.co/9sIY3oWcNV Thanks to @Throb14711 @KhalidAwan7940 @sloane_menkes #cancer #job
The latest Cancer News Daily! https://t.co/9sIY3oWcNV Thanks to @Throb14711 @KhalidAwan7940 @sloane_menkes #cancer #job
— Kidney Cancer (@KidneyCancer) May 23, 2018
2 days ago
In the study’s nine patients with advanced clear cell renal cell carcinoma, four had progressed while on single-agent Opdivo (nivolumab). The group’s best response reached... https://t.co/ScbqQk9s9L
In the study’s nine patients with advanced clear cell renal cell carcinoma, four had progressed while on single-agent Opdivo (nivolumab). The group’s best response reached... https://t.co/ScbqQk9s9L
In the study’s nine patients with advanced clear cell renal cell carcinoma, four had progressed while on single-agent Opdivo (nivolumab). The group’s best response reached... https://t.co/ScbqQk9s9L
— Kidney Cancer (@KidneyCancer) May 22, 2018